Jun Nukui Selected Research

Doxorubicin (Adriamycin)

1/2022

Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Nukui Research Topics

Disease

1	Bloom Syndrome 03/2024
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024
1	Neoplasms (Cancer) 03/2024
1	Genomic Instability 03/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Brain Abscess (Abscess, Brain) 12/2021

Drug/Important Bio-Agent (IBA)

1	Bloom syndrome proteinIBA 03/2024
1	RecQ HelicasesIBA 03/2024
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022

Therapy/Procedure

2	Therapeutics 03/2024 - 12/2021
1	Hematopoietic Stem Cell Transplantation 12/2023
1	Drug Therapy (Chemotherapy) 01/2022